[Ketotifen in allergic diseases].
This study included the review of 1000 clinical histories of allergic diseases, in a retrospective way, that was seeing in the Service of Allergy of the Instituto Nacional de Pediatría in Mexico city. All the patients were previously diagnosed with several allergic pathologiest like: bronchial asthma, rhinitis, asthma and rhinitis, atopic dermatitis, etc. All the patients received as main therapeutic treatment ketotifen at least during 3 months to 12 months. Global improvement in all patients with the use of ketotifen, reach 84%, including all the pathologiest studied. The tolerance of the drug specially in children was very good.
Huerta López
J G
JG
Servicio de Alergia, Instituto Nacional de Pediatría.
D000293:Adolescent; D001249:Asthma / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D003876:Dermatitis, Atopic / Q000188:drug therapy; D005260:Female; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy* / Q000453:epidemiology; D007223:Infant; D007665:Ketotifen / Q000627:therapeutic use*; D008297:Male; D008800:Mexico / Q000453:epidemiology; D012189:Retrospective Studies; D012220:Rhinitis / Q000188:drug therapy
D007665:Ketotifen
Ketotifeno en las enfermedades alérgicas.